The epidermal growth factor receptor (EGFR), a membrane-bound tyrosine kinase receptor, has been found to be a critical oncogene in promoting the tumorigenesis, mitogenesis, and tumor progression of various cancer types, including non-small cell lung cancer (NSCLC) [1, 2]. This evidence concerns the gene EGFR and neoplasm.